36
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva

, , , , &
Pages 1209-1214 | Received 20 Oct 2008, Accepted 03 Sep 2009, Published online: 14 Oct 2009
 

Abstract

Objective. This study aims to evaluate the feasibility and diagnostic validity of the sentinel lymph node technique in detecting inguinal lymph node metastases in patients with invasive squamous cancer of the vulva. Design. Retrospective analysis of the in-house tumor registry. Setting. Dr. Horst Schmidt Klinik, a tertiary gynecologic oncology unit in Wiesbaden, Germany, June 2000–May 2008. Population. All consecutive operated patients with primary envisaged diagnosis were included. Methods. The sentinel node identification technique was performed and patients were informed accordingly. Patients who consented and were found eligible underwent preoperative lymphscintigraphy on the day before surgery. Main outcome measures. Sentinel node detection in specimen from sentinel lymph node biopsy and from full lymphadenectomy (LNE); sentinel lymph node biopsy as a sole surgical groin procedure in patients with histological negative sentinel node; benefit with respect to side effects for sentinel lymph node biopsy compared to full LNE; complication rates; and recurrences of vulvar cancer. Results. In all, 46 of 59 patients with vulvar malignancy underwent inguinofemoral LNE, sentinel lymph node biopsy (SLB) of the groin followed by LNE, or SLB alone. Most patients had been diagnosed in the early stages of the disease. Since no false positive or false negative results were recorded, the sensitivity, specificity, positive predictive value and negative predictive value of the sentinel lymph node were 100%. However, in 6%, a sentinel lymph node could not be detected intraoperatively indicating a feasibility of 94%. Conclusion. The implementation of sentinel lymph node technique for groin staging in squamous cell vulvar cancer seems to provide a feasible and safe technique in tertiary gynecologic oncology.

Acknowledgement

This project was initiated and partially performed while the first author was supported by a grant from the European Society of Gynecologic Oncology (ESGO) within the ESGO fellowship program.

Disclosure of interest: None of the authors declare any potential conflict of interest with respect to the writing of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.